Skip to main content
An official website of the United States government

FDA Regulation of Oncology-related Technologies

The NCI SBIR Development Center connects entrepreneurs with regulatory centers at the US Food and Drug Administration (FDA). These curated links contain resources that are relevant for early-stage companies developing oncology-related technologies.

  • FDA Center for Devices and Radiological Health (CDRH)

    FDA regulates medical devices to assure their safety and effectiveness, and develops and carries out a national program designed to control unnecessary exposures to, and assure safe and efficacious use of, ionizing and non-ionizing radiation-emitting electronic products. The Center for Devices and Radiological Health (CDRH) is the component within the FDA that is responsible for this program.

  • FDA Center for Drug Evaluation and Research (CDER)

    FDA’s Center for Drug Evaluation and Research (CDER) regulates over-the-counter and prescription drugs, including biological therapeutics and generic drugs. CDER's best-known job is to evaluate new drugs before they can be sold. The Center makes sure that safe and effective drugs are available to improve the health of consumers.

  • FDA Center for Biologics Evaluation and Research (CBER)

    The FDA Center for Biologics Evaluation and Research (CBER) regulates biological products, certain human cells and tissue products (HCT/Ps), certain medical devices, HIV test kits and certain drug products.

Contact NCI SBIR

If you have any questions or suggestions for additional resources, please contact NCI SBIR Development Center Program Director Monique Pond (

Frequently Asked Questions (FAQs) about FDA Regulation of Oncology-related Technologies

How do I contact the FDA?
Contact the FDA center that regulates your technology category.

What information is needed for a pre-submission meeting with FDA?
Information needed for pre-submission varies for each of the FDA centers.

What testing requirements/studies are needed to support an Investigational Device Exemption (IDE)?

Overview: Investigational Device Exemption (IDE)

Where can I find information on regulations for laboratory developed tests?

Clinical Laboratory Improvement Amendments (CLIA)

Does my tool qualify for the Medical Device Development Tools (MDDT) program?

Medical Device Development Tools (MDDT)

Is Premarket Notification 510(k) or Premarket Approval (PMA) required for my device?

Can my device be reviewed by FDA and Centers for Medicare and Medicaid Services (CMS) in parallel?

Payor Communication Task Force

What should I know for my pre-IND meeting?

Small Business and Industry Assistance: Frequently Asked Questions on the Pre-Investigational New Drug (IND) Meeting

Is my therapy eligible for the Regenerative Medicine Advanced Therapy (RMAT) designation?

Regenerative Medicine Advanced Therapy Designation